BLUESKEYE AI, a global leader in ethical artificial intelligence to objectively MEASURE social, emotional, and medically relevant expressed behaviour, BETTER than ever before, today announced it has been selected for a prestigious spot in the Google for Startups’ Growth Academy: AI for Health—an exclusive, game-changing program that supports promising AI-powered health innovation companies with the goal of enabling a positive impact on global healthcare systems.
The programme saw 25 companies from Europe, the Middle East, and Africa chosen after a rigorous selection process. Blueskeye is one of only three companies participating in the programme from the UK. In May, two of Blueskeye’s founders will head to Poland to kick off the three-month hybrid programme.
BLUESKEYE AI measures what was previously unmeasurable. Whereas the current gold standard for mental health assessment typically relies on infrequent and subjective self-reports or lengthy in-person clinical interviews, Blueskeye provides objective, honest, and fast measurement of the severity of anxiety, depression, fatigue, and other medical conditions that change the way you express yourself through face and voice behaviour. This will help prevent costly treatment through early intervention, and enable precision medicine.
Today, Blueskeye provides face and voice analysis to customers in the Automotive, Health, and Social Robotics markets. In the Health space, its B-Healthy Platform supports clinical trials with clinical grade app-delivered tasks that let pharmaceutical companies collect ecologically valid data of previously unavailable digital endpoints. B-Healthy can help healthcare professionals and life science companies collect objective health measures, better understand patient conditions, and design personalised responses which could provide wider access to Blueskeye’s innovations.
Professor Michel Valstar, founder and Blueskeye’s Chief Evangelist and Scientific Officer said: “The Google For Startups program is a fantastic opportunity for BLUESKEYE AI as we continue to strengthen our position in the market. With ongoing clinical trials and increasing adoption of our technology, the program’s access to global experts, peer innovators, and ongoing mentorship will provide invaluable support as we continue our commercial growth and prepare for team expansion.”
Noam Feinstein, Senior Startup Partner Manager and Campus Lead at Google for Startups, added: “We’re excited to welcome BLUESKEYE AI to the Growth Academy: AI for Health. Their integrated approach to transforming healthcare with AI stood out in our selection process. Google is proud to support their mission and connect them with other visionary companies who are redefining the future of health.”
Participants in the program will benefit from virtual and in-person sessions focused on AI best practices, product design, leadership, responsible innovation, and customer growth, with ongoing technical support from Google’s expert teams—even after the programme ends.
About BLUESKEYE AI:
BLUESKEYE AI uses machine learning to objectively MEASURE social, emotional, and medically relevant expressed face and voice behaviour, BETTER than ever before. This helps clinicians, patients and their friends and families assess, treat and monitor health, mood and mental state. Its solutions span across healthcare, automotive, social robotics and other industries.
Learn more at www.blueskeye.com